Esther Rajavelu Spero Therapeutics, Inc. (SPRO) insider trading activity

SPRO Quotes by TradingView

Esther Rajavelu is CFO & CBO of Spero Therapeutics, Inc.. Currently has a direct ownership of 379,270 shares of SPRO, which is worth approximately $390,648. The most recent transaction as insider was on Nov 08, 2024, when has been sold 17,245 shares (Common Stock) at a price of $1.3 per share, resulting in proceeds of $22,418. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 379K
9.67% 3M change
26.42% 12M change
Total Value Held $390,648

Esther Rajavelu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2024
SELL
Open market or private sale
$22,418 $1.3 p/Share
17,245 Reduced 4.35%
379,270 Common Stock
Nov 07 2024
SELL
Open market or private sale
$30,589 $1.31 p/Share
23,351 Reduced 5.56%
396,515 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
119,866 Added 22.21%
419,866 Common Stock
Nov 13 2023
BUY
Grant, award, or other acquisition
-
300,000 Added 50.0%
300,000 Common Stock

Also insider at

FULC
Fulcrum Therapeutics, Inc. Healthcare
Chief Financial Officer
ER

Esther Rajavelu

CFO & CBO
Cambridge, MA

Track Institutional and Insider Activities on SPRO

Follow Spero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if

News

Receive news related to Spero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SPRO